Literature DB >> 24033296

Incidence of haematological malignancies by ethnic group in England, 2001-7.

Megan H Shirley1, Shameq Sayeed, Isobel Barnes, Alexander Finlayson, Raghib Ali.   

Abstract

The aetiology of most haematological malignancies is largely unknown. Studies of migrant populations can provide insights into the relative importance of genetic and environmental risk factors for these diseases. This study compares incidence rates in British Indians, Pakistanis, Bangladeshis, Black Africans, Black Caribbeans, Chinese and Whites in England from 2001 to 2007. We analysed 134,302 haematological cancer registrations with ethnicity obtained by linkage to the Hospital Episodes Statistics database. Mid-year population estimates from 2001 to 2007 were used. Incidence rate ratios adjusted for age, sex and income were calculated, comparing the six ethnic groups to Whites and to each other. Whites had the highest rates for most subtypes. However, Blacks experienced more than double the incidence of plasma cell and mature T-cell neoplasms compared to other ethnic groups. There were also significant differences in incidence between Indians, Pakistanis and Bangladeshis for Hodgkin lymphoma and mature B-cell neoplasms and between Black African and Black Caribbeans for mature B-cell and other lymphoid neoplasms (all P < 0.001). Our results show that the risk of haematological cancers varies greatly by ethnic group, including within those groups that have traditionally been grouped together (South Asians and Blacks) with many of these differences not explicable by known risk factors.
© 2013 John Wiley & Sons Ltd.

Entities:  

Keywords:  ethnicity; haematological malignancy; incidence; leukaemia; lymphoma

Mesh:

Year:  2013        PMID: 24033296     DOI: 10.1111/bjh.12562

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  19 in total

Review 1.  Current challenges in the management of follicular lymphoma.

Authors:  Maryam Sarraf Yazdy; Chaitra Ujjani
Journal:  Int J Hematol Oncol       Date:  2017-06-30

Review 2.  Follicular lymphoma: first-line treatment without chemotherapy for follicular lymphoma.

Authors:  Patrick M Reagan; Jonathan W Friedberg
Journal:  Curr Treat Options Oncol       Date:  2015-07

3.  DNA methylation and leukemia susceptibility in China: Evidence from an updated meta-analysis.

Authors:  Danjie Jiang; Yirun Li; Qingxiao Hong; Yusheng Shen; Chunjing Xu; Yan Xu; Huangkai Zhu; Dongjun Dai; Guifang Ouyang; Shiwei Duan
Journal:  Mol Clin Oncol       Date:  2016-07-12

4.  Ethnic and geographic diversity of chronic lymphocytic leukaemia.

Authors:  Shenmiao Yang; Abraham M Varghese; Nitin Sood; Carlos Chiattone; Norah O Akinola; Xiaojun Huang; Robert Peter Gale
Journal:  Leukemia       Date:  2020-10-19       Impact factor: 11.528

Review 5.  Epidemiology of Follicular Lymphoma.

Authors:  James R Cerhan
Journal:  Hematol Oncol Clin North Am       Date:  2020-05-05       Impact factor: 3.722

6.  A phase 3 randomized study (HOMER) of ofatumumab vs rituximab in iNHL relapsed after rituximab-containing therapy.

Authors:  David G Maloney; Michinori Ogura; Noriko Fukuhara; Jaclyn Davis; Janet Lasher; Miguel Izquierdo; Hiya Banerjee; Kensei Tobinai
Journal:  Blood Adv       Date:  2020-08-25

7.  Incidence of prostate and urological cancers in England by ethnic group, 2001-2007: a descriptive study.

Authors:  Mahiben Maruthappu; Isobel Barnes; Shameq Sayeed; Raghib Ali
Journal:  BMC Cancer       Date:  2015-10-21       Impact factor: 4.430

8.  Incidence of breast and gynaecological cancers by ethnic group in England, 2001-2007: a descriptive study.

Authors:  Megan H Shirley; Isobel Barnes; Shameq Sayeed; Alexander Finlayson; Raghib Ali
Journal:  BMC Cancer       Date:  2014-12-18       Impact factor: 4.430

Review 9.  Follicular Lymphoma: The Management of Elderly Patient.

Authors:  Alessia Castellino; Elisa Santambrogio; Maura Nicolosi; Barbara Botto; Carola Boccomini; Umberto Vitolo
Journal:  Mediterr J Hematol Infect Dis       Date:  2017-01-01       Impact factor: 2.576

10.  Exon-centric regulation of ATM expression is population-dependent and amenable to antisense modification by pseudoexon targeting.

Authors:  Jana Kralovicova; Marcin Knut; Nicholas C P Cross; Igor Vorechovsky
Journal:  Sci Rep       Date:  2016-01-06       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.